Table 1 Characteristics of patients treated with FP or DCF therapy

Age

Median (range)

64 (48–76)

63 (47–75)

0.137 ^a

Sex

male / female

41 / 9

25 / 6

0.879 ^b

Performance status

0 / 1

47 / 3

29 / 2

0.653 ^c

Tumor location

Ce / Ut / Mt / Lt / Ae

2 / 4 / 29 / 14 / 1

1 / 5 / 11 / 13 / 1

0.359 ^b

The degree of differentiation

well / moderate / poorly / unknown

7 / 20 / 18 / 5

4 / 14 / 8 / 5

0.720 ^b

Tumor length in major axis

(cm)

Mean ± SD

5.3 ± 2.5

7.3 ± 3.7

*0.005 ^a

cStage (11th JES)

II / III / IVa

17 / 20 / 13

3 / 17 / 11

*0.048 ^b

pT (11th JES)

0-1a / 1b / 2 / 3 / 4

4 / 11 / 5 / 26 / 4

6 / 2 / 5 / 14 / 4

0.199 ^b

pN (11th JES)

0 / 1 / 2 / 3 / 4

17 / 4 / 13 / 6 / 10

7 / 2 / 12 / 3 / 7

0.786 ^b

pStage (11th JES)

I / II / III / IVa

4 / 14 / 19 / 13

2 / 5 / 12 / 12

0.529 ^b